Skip to main content
. 2020 Aug;1(4):e165–e174. doi: 10.1016/S2666-5247(20)30031-8

Table 3.

Clofazimine MICs of 20 isolates tested on 7H11 agar with the 1% proportion method, showing number of isolates that have genetically wild-type Rv0678 and those with Rv0678 variants

0·12 μg/mL 0·25 μg/mL 0·5 μg/mL 1·0 μg/mL 2·0 μg/mL 4·0 μg/mL
H37Rv 1 2 .. .. .. ..
Clinical isolates
Wild type 2 4 1 .. .. ..
Val1Ala/Gly37fs/Arg89Trp .. .. 1 ... .. ..
Val20Gly .. .. .. .. .. 1
Gln22Pro/Asp47fs .. .. .. .. 2* ..
Cys46fs .. .. .. .. 1 ..
Cys46fs/Asp47fs .. .. .. .. 2 ..
Asp47fs .. .. .. .. 2 ..
Asp47fs/Ile67fs/Leu136Arg .. .. .. .. 1 ..
Glu49fs .. 1 .. .. 1 ..
Ile67fs .. .. .. .. 1 1
Phe93Ser .. .. .. 2 .. ..
Arg109Leu/Arg156fs .. .. .. 1 1 ..
Ala118Thr .. .. 1 .. .. ..
Glu147fs .. .. 1 .. .. ..

Mycobacterium tuberculosis strain H37Rv was included in each batch for quality control. WHO has not yet determined a critical concentration for clofazimine on 7H11 agar. MIC measurement failed for one (P0121, carrying the Phe93Leu RAV; appendix p 8, 19) of the 21 clinical isolates with Rv0678 variants we included in our analysis. MIC=minimum inhibitory concentration.

*

One isolate had an additional six Rv0678 mutations below 15% allele frequency.